Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05544513
PHASE2

Oral Iron Supplementation for Patients With Chronic Kidney Disease

Sponsor: Universidade Federal Fluminense

View on ClinicalTrials.gov

Summary

The hypothesis of this research is that oral iron prescribed in a single dose in alternate day could mitigate the side effects with regard to intestinal microbiota, inflammation, oxidative stress and improve the hematological profile when compared to daily oral iron prescription

Official title: Effects of Oral Iron Supplementation on Gut Microbiota in Patients With Chronic Kidney Disease

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

6

Start Date

2022-08-01

Completion Date

2026-12-30

Last Updated

2025-04-03

Healthy Volunteers

No

Interventions

DRUG

Ferrous sulfate 3 days week

Participants will receive one ferrous sulfate capsule (120 mg of elemental iron) on Mondays, Wednesdays and Fridays

DRUG

Ferrous sulfate daily

Participants will receive one ferrous sulfate (120 mg of elemental iron) capsule daily (except on Sundays)

DRUG

Ferrous sulfate higher concentration

Participants will receive one ferrous sulfate capsule (240mg of elemental iron) on Mondays, Wednesdays and fridays

Locations (1)

Denise Mafra

Rio de Janeiro, Rio de Janeiro, Brazil